Article
EGFR mutation testing using archival-stained smears in non-small cell lung carcinoma.
Cytopathology : official journal of the British Society for Clinical Cytology - 1 Feb 2017
Ozluk Y, Firat P, Yegen G, Hocaoglu J, Tas S, Yilmazbayhan D
Abstract excerpt
OBJECTIVE: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have shown benefits regarding progression-free and overall survival in patients whose tumours show EGFR mutations. Most patients' lung cancer is metastatic when detected. Small tissue samples and cytological materials are widely used in diagnosis. The aim of the present study was to compare the EGFR mutation analysis results...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
